Regulation of transgene expression in genetic immunization

Brazilian Journal of Medical and Biological Research

Volumn 32, Issue 2, 1999, Pages 155-162

  Harms, J S ^a,c   Oliveira, S C ^b   Splitter, C A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c AHABS   (United States)

Author keywords

DNA vaccine; Gene therapy; Regulation; Transcription; Transgene

Indexed keywords

CUCUMBER MOSAIC VIRUS; MAMMALIA;

DNA VACCINE; LUCIFERASE;

ARTICLE; CYTOMEGALOVIRUS; ENHANCER REGION; GENE; GENE EXPRESSION REGULATION; GENE VECTOR; PROMOTER REGION; SIMIAN VIRUS 40; TRANSGENE;

CYTOMEGALOVIRUS; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION; GENES, MHC CLASS I; GENETIC VECTORS; LUCIFERASES; PROMOTER REGIONS (GENETICS); SIMIAN VIRUS 40; TRANSGENES; VACCINES, DNA;

EID: 0033073314     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1999000200003     Document Type: Article

References (28)

1. Ertl HCJ & Xiang ZQ (1996). Genetic immunization. Viral Immunology, 9: 1-9.
2. Felgner PL & Rhodes G (1991). Gene therapeutics. Nature, 349: 351-352.
3. Gilboa E & Smith C (1994). Gene therapy for infectious diseases: The AIDS model. Trends in Genetics, 10: 139-144.
4. Tighe H, Corr M, Roman M & Raz E (1998). Gene vaccination: plasmid DNA is more than just a blueprint. Immunology Today, 19: 89-97.
5. Thompson L (1992). At age 2, gene therapy enters a growth phase Science, 258: 744-746.
6. Xiang ZQ, Pasquini S, He Z, Deng H, Wang Y, Blaszczyk-Thurin MA & Ertl HCJ (1997). Genetic vaccines - a revolution in vaccinology? Springer Seminars in Immunopathology, 19: 257-268.
7. Harms JS, Li W & Splitter GA (1995). The cattle major histocompatibility complex (MHC) class-I possesses HLA-like promoters. Gene, 160: 249-252.
8. Cheng L, Ziegelhoffer PR & Yang NS (1993). In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proceedings of the National Academy of Sciences, USA, 90: 4455-4459.
9. Singer DS & Maguire JE (1990). Regulation of the expression of class I MHC genes. Critical Reviews in Immunology, 10: 235-256
10. Espel E, Fromental C, Reichenbach P & Nabholz M (1990). Activity and interleukin 1 responsiveness of SV40 enhancer motifs in a rodent immature T cell line. EMBO Journal, 9: 929-937.
11. Ghazal P, Lubon H, Reynolds-Kohler C, Hennighausen L & Nelson JA (1990). Interactions between cellular regulatory proteins and a unique sequence region in the human cytomegalovirus major immediate-early promoter Virology, 174: 18-25.
12. Israel A, Le Bail O, Hatat D, Piette J, Kieran M, Logeat F, Wallach D, Fellous M & Kourilsky P (1989). TNF stimulates expression of mouse MHC class I genes by inducing an NFkB-like enhancer binding activity which displaces constitutive factors. EMBO Journal, 8: 3793-3800.
13. Gribaudo G, Ravaglia S, Caliendo A, Cavallo R, Gariglio M, Martinotti MG & Landolfo S (1993). Interferons inhibit onset of murine cytomegalovirus immediate-early gene transcription. Virology, 197: 303-311.
14. Kerr IM & Stark GR (1992). The antiviral effects of the interferons and their inhibition. Journal of Interferon Research, 12: 237-240.
15. Korber B, Mermod N, Hood L & Stroynowski I (1988). Regulation of gene expression by interferons: Control of H-2 promoter responses Science, 239: 1302-1306.
16. Shirayoshi Y, Burke PA, Appella E & Ozato K (1988). Interferor-induced transcription of a major histocompatibility class I gene accompanies binding of inducible nuclear factors to the interferon consensus sequence. Proceedings of the National Academy of Sciences, USA, 85: 5884-5888.
17. Jiao S, Williams P, Berg RK. Hodgeman BA, Liu L, Repetto G & Wolff JA (1992). Direct gene transfer into nonhuman primate myofibers in vivo. Human Gene Therapy, 3: 21-33.
18. Ulmer JB, Donnelly JJ, Deck RR, Dewitt CM, Dwarki VJ, Felgner PL, Freidman A, Hawe LA, Leander KK, Martinez D, Parker SE, Perry HC, Rhodes GH, Shiver JW, Montgomery DI & Liu MA (1993). Heterologous protective immunity to influenza A by intramuscular injection of DNA encoding a conserved viral protein. Science, 259: 1745-1749.
19. Yang NS (1992). Gene transfer into mammalian somatic cells in vivo. Critical Reviews in Biotechnology, 12: 335-356.
20. Blanchet O, Bourge JF, Zinszner H, Tatari Z, Degos L & Paul P (1991). DNA binding of regulatory factors interacting with MHC-class-I gene enhancer correlates with MHC-class-I transcriptional level in class-I-defective cell lines. International Journal of Cancer, Suppl 6: 138-145.
21. Pavic I, Polic B, Crnkovic I, Lucin P, Jonjic S & Koszinowski UH (1993). Participation of endogenous tumour necrosis factor α in host resistance to cytomegalovirus infection. Journal of General Virology, 74: 2215-2223.
22. Manthorpe M, Cornefert-Jensen F, Hartikka J, Felgner J, Rundell A, Margalith M & Dwarki V (1993). Gene therapy by intramuscular injection of plasmid DNA: Studies on firefly luciferase gene expression in mice. Human Gene Therapy, 4: 419-431.
23. Schmidt EV, Christoph G, Zeller R & Leder P (1990). The cytomegalovirus enhancer: A pan-active control element in transgenic mice. Molecular and Cellular Biology, 10: 4406-4411.
24. Takebe Y, Seiki M, Fujisawa J. How P, Yokota K, Arai K, Yoshida M & Arai N (1988). SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Molecular and Cellular Biology, 8: 466-472.
25. Thompson TA, Gould MN, Burkholder JK & Yang NS (1993). Transient promoter activity in primary rat mammary epithelial cells evaluated using particle bombardment gene transfer. In Vitro Cellular and Developmental Biology, 29A: 165-170.
26. Artelt P, Grannemann R, Stocking C, Friel J, Bartsch J & Hauser H (1991). The prokaryotic neomycin-resistance-encoding gene acts as a transcriptional silencer in eukaryotic cells. Gene, 99: 249-254.
27. Valera A, Perales JC, Hatzouglou M & Bosch F (1994). Expression of the neomycin-resistance (neo) gene induces alterations in gene expression and metabolism. Human Gene Therapy, 5: 449-456.
28. Xiang ZQ, He Z, Wang Y & Ertl HCJ (1997). The effect of interferon-γ on genetic immunization. Vaccine, 15: 896-898.